Process View
Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of interleukin 5 production"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RXRA | retinoid X receptor, alpha | 1.000 | ||
| MED25 | mediator complex subunit 25 | 1.000 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 1.000 | ||
| NCOA1 | nuclear receptor coactivator 1 | 1.000 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.999 | ||
| RARA | retinoic acid receptor, alpha | 0.991 | ||
| PHYHIPL | phytanoyl-CoA 2-hydroxylase interacting protein-like | 0.985 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.979 | ||
| ZNF71 | zinc finger protein 71 | 0.925 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.923 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.880 | ||
| RXRB | retinoid X receptor, beta | 0.877 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.870 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.843 | ||
| NUMB | numb homolog (Drosophila) | 0.803 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.801 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.773 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.718 | ||
| NMT2 | N-myristoyltransferase 2 | 0.681 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.572 | ||
| MED1 | mediator complex subunit 1 | 0.539 | ||
| TBX5 | T-box 5 | 0.462 | ||
| RXRG | retinoid X receptor, gamma | 0.454 | ||
| KANK2 | KN motif and ankyrin repeat domains 2 | 0.413 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.350 | ||
| F11R | F11 receptor | 0.249 | ||
| KLF13 | Kruppel-like factor 13 | 0.243 | ||
| PRKD2 | protein kinase D2 | 0.224 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.218 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.211 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.201 | ||
| TRIM32 | tripartite motif containing 32 | 0.201 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.198 | ||
| RUNX1 | runt-related transcription factor 1 | 0.197 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.193 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.178 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.163 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.155 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.131 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.115 | ||
| CREBBP | CREB binding protein | 0.111 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.109 | ||
| PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 | 0.102 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.101 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.097 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.096 | ||
| ESR1 | estrogen receptor 1 | 0.094 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.087 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.086 | ||
| GATA2 | GATA binding protein 2 | 0.085 | Human | |
| NCOA6 | nuclear receptor coactivator 6 | 0.078 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.078 | ||
| PGR | progesterone receptor | 0.076 | ||
| NR2F6 | nuclear receptor subfamily 2, group F, member 6 | 0.074 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.066 | ||
| FOXJ1 | forkhead box J1 | 0.064 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.064 | ||
| PRKCI | protein kinase C, iota | 0.063 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.057 | ||
| DENND5A | DENN/MADD domain containing 5A | 0.056 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.054 | ||
| CREM | cAMP responsive element modulator | 0.054 | ||
| STK4 | serine/threonine kinase 4 | 0.050 | ||
| CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.048 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.047 | ||
| ADAP1 | ArfGAP with dual PH domains 1 | 0.044 | ||
| LLGL2 | lethal giant larvae homolog 2 (Drosophila) | 0.043 | ||
| AMHR2 | anti-Mullerian hormone receptor, type II | 0.042 | ||
| TADA3 | transcriptional adaptor 3 | 0.042 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.041 | ||
| ASXL1 | additional sex combs like 1 (Drosophila) | 0.041 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.041 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.041 | ||
| WWC1 | WW and C2 domain containing 1 | 0.040 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.037 | Human | |
| SPOP | speckle-type POZ protein | 0.037 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.037 | Human | |
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.037 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.037 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.036 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.035 | ||
| KLF1 | Kruppel-like factor 1 (erythroid) | 0.035 | ||
| ACVR1B | activin A receptor, type IB | 0.034 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.034 | ||
| THEM4 | thioesterase superfamily member 4 | 0.033 | ||
| NR1D1 | nuclear receptor subfamily 1, group D, member 1 | 0.033 | Human | |
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.033 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.033 | ||
| HR | hairless homolog (mouse) | 0.033 | ||
| PDE7B | phosphodiesterase 7B | 0.031 | Human | |
| ZNF576 | zinc finger protein 576 | 0.030 | ||
| NPAS2 | neuronal PAS domain protein 2 | 0.030 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.029 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.028 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.028 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.027 | ||
| SPIN1 | spindlin 1 | 0.027 | ||
| SPHK1 | sphingosine kinase 1 | 0.026 | ||
| GATA4 | GATA binding protein 4 | 0.026 | Human | |
| DHH | desert hedgehog | 0.025 | ||
| PNRC1 | proline-rich nuclear receptor coactivator 1 | 0.024 | ||
| HDAC3 | histone deacetylase 3 | 0.023 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.022 | Human | |
| GATA5 | GATA binding protein 5 | 0.022 | Human | |
| LNX1 | ligand of numb-protein X 1 | 0.022 | ||
| ACY3 | aspartoacylase (aminocyclase) 3 | 0.022 | ||
| RARG | retinoic acid receptor, gamma | 0.021 | Human | |
| DAB2IP | DAB2 interacting protein | 0.021 | ||
| SLC6A9 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | 0.021 | ||
| ALX4 | ALX homeobox 4 | 0.020 | ||
| PTPRU | protein tyrosine phosphatase, receptor type, U | 0.020 | ||
| CRABP2 | cellular retinoic acid binding protein 2 | 0.020 | ||
| HDC | histidine decarboxylase | 0.020 | ||
| ZBTB38 | zinc finger and BTB domain containing 38 | 0.019 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.019 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.019 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.018 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.018 | ||
| SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.018 | ||
| PNMT | phenylethanolamine N-methyltransferase | 0.018 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.018 | ||
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.018 | ||
| HOXB9 | homeobox B9 | 0.018 | ||
| FAM129A | family with sequence similarity 129, member A | 0.018 | ||
| IL24 | interleukin 24 | 0.018 | ||
| MED29 | mediator complex subunit 29 | 0.018 | ||
| MBNL2 | muscleblind-like 2 (Drosophila) | 0.017 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.017 | ||
| RTKN | rhotekin | 0.017 | ||
| SERGEF | secretion regulating guanine nucleotide exchange factor | 0.017 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.017 | ||
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.017 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.016 | ||
| CTSE | cathepsin E | 0.016 | ||
| BAD | BCL2-associated agonist of cell death | 0.016 | ||
| SOCS7 | suppressor of cytokine signaling 7 | 0.016 | ||
| ATXN1L | ataxin 1-like | 0.016 | ||
| PRKCQ | protein kinase C, theta | 0.016 | ||
| BHLHE23 | basic helix-loop-helix family, member e23 | 0.016 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.016 | ||
| DLG5 | discs, large homolog 5 (Drosophila) | 0.016 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.015 | ||
| THSD4 | thrombospondin, type I, domain containing 4 | 0.015 | ||
| HIC1 | hypermethylated in cancer 1 | 0.015 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.015 | ||
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 0.015 | ||
| LSR | lipolysis stimulated lipoprotein receptor | 0.015 | ||
| ZFPM2 | zinc finger protein, multitype 2 | 0.015 | ||
| PAX9 | paired box 9 | 0.014 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.014 | ||
| RORA | RAR-related orphan receptor A | 0.014 | ||
| LYL1 | lymphoblastic leukemia derived sequence 1 | 0.014 | ||
| DLC1 | deleted in liver cancer 1 | 0.014 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.014 | ||
| EYA4 | eyes absent homolog 4 (Drosophila) | 0.014 | ||
| CLDN11 | claudin 11 | 0.014 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.014 | ||
| NTF3 | neurotrophin 3 | 0.014 | ||
| EFNB1 | ephrin-B1 | 0.014 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.014 | ||
| STAC | SH3 and cysteine rich domain | 0.014 | ||
| AKAP6 | A kinase (PRKA) anchor protein 6 | 0.014 | ||
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 0.013 | ||
| CLCF1 | cardiotrophin-like cytokine factor 1 | 0.013 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.013 | ||
| CACNB1 | calcium channel, voltage-dependent, beta 1 subunit | 0.013 | ||
| DIO3 | deiodinase, iodothyronine, type III | 0.013 | ||
| ANK1 | ankyrin 1, erythrocytic | 0.013 | ||
| TBX1 | T-box 1 | 0.013 | ||
| WT1 | Wilms tumor 1 | 0.013 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.013 | ||
| PIK3R4 | phosphoinositide-3-kinase, regulatory subunit 4 | 0.013 | ||
| VTN | vitronectin | 0.013 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.013 | ||
| NR3C2 | nuclear receptor subfamily 3, group C, member 2 | 0.013 | ||
| MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) | 0.013 | ||
| DUSP4 | dual specificity phosphatase 4 | 0.012 | ||
| HOXC5 | homeobox C5 | 0.012 | ||
| ZFHX4 | zinc finger homeobox 4 | 0.012 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.012 | ||
| ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | 0.012 | ||
| RARB | retinoic acid receptor, beta | 0.012 | Human | |
| GYPB | glycophorin B (MNS blood group) | 0.012 | ||
| RAB30 | RAB30, member RAS oncogene family | 0.012 | ||
| ETV1 | ets variant 1 | 0.012 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.012 | ||
| DCP1A | DCP1 decapping enzyme homolog A (S. cerevisiae) | 0.012 | ||
| ESRRG | estrogen-related receptor gamma | 0.012 | ||
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 0.012 | ||
| INPP4B | inositol polyphosphate-4-phosphatase, type II, 105kDa | 0.012 | ||
| PAX5 | paired box 5 | 0.012 | ||
| AVPR1A | arginine vasopressin receptor 1A | 0.012 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.012 | ||
| FHL1 | four and a half LIM domains 1 | 0.012 | ||
| BDNF | brain-derived neurotrophic factor | 0.012 | ||
| SIRT6 | sirtuin 6 | 0.012 | ||
| APBA1 | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.012 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.012 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.012 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.012 | ||
| MED26 | mediator complex subunit 26 | 0.012 | ||
| APOA4 | apolipoprotein A-IV | 0.012 | ||
| FHIT | fragile histidine triad gene | 0.012 | ||
| ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | 0.012 | ||
| GP9 | glycoprotein IX (platelet) | 0.011 | ||
| ZBTB7A | zinc finger and BTB domain containing 7A | 0.011 | ||
| BMP6 | bone morphogenetic protein 6 | 0.011 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.011 | ||
| DACH1 | dachshund homolog 1 (Drosophila) | 0.011 | ||
| CD69 | CD69 molecule | 0.011 | ||
| C5orf41 | chromosome 5 open reading frame 41 | 0.011 | ||
| AFTPH | aftiphilin | 0.011 | ||
| TFR2 | transferrin receptor 2 | 0.011 | ||
| PRKG2 | protein kinase, cGMP-dependent, type II | 0.011 | ||
| MEF2A | myocyte enhancer factor 2A | 0.011 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.011 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.011 | ||
| CYP4F22 | cytochrome P450, family 4, subfamily F, polypeptide 22 | 0.011 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.011 | ||
| CAPN5 | calpain 5 | 0.011 | ||
| PKIA | protein kinase (cAMP-dependent, catalytic) inhibitor alpha | 0.011 | ||
| KEL | Kell blood group, metallo-endopeptidase | 0.011 | ||
| SLC4A7 | solute carrier family 4, sodium bicarbonate cotransporter, member 7 | 0.010 | ||
| FYCO1 | FYVE and coiled-coil domain containing 1 | 0.010 | ||
| ATF7 | activating transcription factor 7 | 0.010 | ||
| HOXC8 | homeobox C8 | 0.010 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.010 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.010 | ||
| CISH | cytokine inducible SH2-containing protein | 0.010 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.010 | ||
| HDAC10 | histone deacetylase 10 | 0.010 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.010 | ||
| HDAC7 | histone deacetylase 7 | 0.010 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.010 | ||
| RNF152 | ring finger protein 152 | 0.010 | ||
| CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 0.010 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.010 | ||
| FHOD3 | formin homology 2 domain containing 3 | 0.010 | ||
| ACVR2A | activin A receptor, type IIA | 0.010 | ||
| TBX3 | T-box 3 | 0.010 | ||
| FUT1 | fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) | 0.010 | ||
| GDNF | glial cell derived neurotrophic factor | 0.010 | ||
| F2RL2 | coagulation factor II (thrombin) receptor-like 2 | 0.010 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.010 | ||
| ZDHHC17 | zinc finger, DHHC-type containing 17 | 0.010 | ||
| ARID5B | AT rich interactive domain 5B (MRF1-like) | 0.010 | ||
| ZBED5 | zinc finger, BED-type containing 5 | 0.010 | ||
| NLK | nemo-like kinase | 0.010 | ||
| SEMA6D | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D | 0.010 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.010 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.010 | ||
| RHAG | Rh-associated glycoprotein | 0.010 | ||
| NRP2 | neuropilin 2 | 0.010 | ||
| PF4 | platelet factor 4 | 0.010 |